Live Breaking News & Updates on Alkermes

Stay informed with the latest breaking news from Alkermes on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alkermes and stay connected to the pulse of your community

Q3 2025 EPS Estimates for Alkermes plc Raised by Zacks Research (NASDAQ:ALKS)

Alkermes plc (NASDAQ:ALKS – Free Report) – Analysts at Zacks Research lifted their Q3 2025 earnings per share estimates for Alkermes in a report released on Wednesday, April 10th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.52 for the quarter, up from their prior estimate of […]

United-states , Ireland , Christian-todd-nichols , Piper-sandler , Robertw-baird , Alps-advisors-inc , Vanguard-personalized-indexing-management , Alkermes , Nasdaq , Analysts-at-zacks-research , Zacks-research , Jefferies-financial-group

FY2027 EPS Estimates for Alkermes plc (NASDAQ:ALKS) Decreased by Leerink Partnrs

Alkermes plc (NASDAQ:ALKS – Free Report) – Research analysts at Leerink Partnrs dropped their FY2027 earnings per share (EPS) estimates for shares of Alkermes in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of $1.35 for the year, […]

Ireland , United-states , Los-angeles , California , America , Piper-sandler , Leerink-partnrs , Christian-todd-nichols , Los-angeles-capital-management , Nasdaq , Financial-services-group-inc , Vanguard-group-inc

FY2027 Earnings Estimate for Alkermes plc (NASDAQ:ALKS) Issued By Leerink Partnrs

Alkermes plc (NASDAQ:ALKS – Free Report) – Equities researchers at Leerink Partnrs reduced their FY2027 earnings estimates for Alkermes in a research report issued on Tuesday, April 9th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of $1.35 for the year, down from their prior estimate of $1.45. […]

Ireland , Wellington , New-zealand-general- , New-zealand , United-states , America , Leerink-partnrs , Christian-todd-nichols , Robertw-baird , Pearl-river-capital , Nasdaq , Allspring-global-investments-holdings

Alkermes' Innovations Are Transforming Mental Health Treatments

A closer look at one of the leaders in the global bipolar disorder treatment market

United-states , Americans , Mental-health-services-administration , Amneal-pharmaceuticals , Alkermes , World-health-organization , Johnson , Substance-abuse , Teva-pharmaceutical , President-biden , Inflation-reduction

Kiwanis annual bike rodeo returns May 18 - Wilmington News Journal

Kiwanis annual bike rodeo returns May 18 - Wilmington News Journal
wnewsj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnewsj.com Daily Mail and Mail on Sunday newspapers.

Alkermes , Clinton-memorial-hospital , Luther-warren-peace-path , Kiwanis-facebook ,

ALKS 2680 Improves Wakefulness in Narcolepsy Type 2 and IH

Alkermes plc announced positive results from a phase 1b study evaluating ALKS 2680 for treating narcolepsy type 2 and idiopathic hypersomnia.

Ron-grunstein , Alkermes , Woolcock-institute-of-medical-research , Wakefulness-test , Woolcock-institute , Medical-research ,

Buy Rating Affirmed for Alkermes on Promising ALKS 2680 Clinical Trial Results and Growth Potential

Goldman Sachs analyst Chris Shibutani has maintained their bullish stance on ALKS stock, giving a Buy rating yesterday. Chris Shibutani has giv...

Arcutis-biotherapeutics , Chris-shibutani , Goldman-sachs , Alkermes , Merck-company , Tipranks-premium ,

Alkermes plc (NASDAQ:ALKS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Alkermes plc (NASDAQ:ALKS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The […]

United-states , Wellington , New-zealand-general- , New-zealand , Ireland , America , Piper-sandler , Christian-todd-nichols , Robertw-baird , Rafferty-asset-management , Securities-exchange-commission , Wellington-management-group

Moody Aldrich Partners LLC Purchases 12,496 Shares of Alkermes plc (NASDAQ:ALKS)

Moody Aldrich Partners LLC boosted its position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 31.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,570 shares of the company’s stock after purchasing an additional 12,496 shares during […]

United-states , Ireland , Blackrock , Louth , Wellington , New-zealand-general- , New-zealand , America , Piper-sandler , Robertw-baird , Christian-todd-nichols , Moody-aldrich-partners

Moody Aldrich Partners LLC Grows Position in Alkermes plc (NASDAQ:ALKS)

Moody Aldrich Partners LLC lifted its stake in Alkermes plc (NASDAQ:ALKS – Free Report) by 31.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 52,570 shares of the company’s stock after buying an additional 12,496 shares during the quarter. Moody Aldrich Partners LLC’s holdings in Alkermes […]

Wellington , New-zealand-general- , New-zealand , United-states , Ireland , America , Christian-todd-nichols , Piper-sandler , Arrowstreet-capital-limited-partnership , Nasdaq , Alkermes , Moody-aldrich-partners